SFCM
AMLX icon

Seven Fleet Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Seven Fleet Capital Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Buy
16,671
+5,100
+44% +$71.7K 0.07% 101
2025
Q4 		$140K Buy
+11,571
New +$157K 0.09% 68

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Seven Fleet Capital Management's AMLX Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Amylyx Pharmaceuticals (AMLX) stake by 44% in Q1 2026, buying an estimated $71.7K and bringing the position to 16,671 shares worth $232K. The position accounts for 0.07% of the portfolio, ranked #101.

Seven Fleet Capital Management first reported a position in AMLX in Q4 2025 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Seven Fleet Capital Management held 16,671 shares of Amylyx Pharmaceuticals worth $232K as of Q1 2026.
  • Seven Fleet Capital Management bought 5,100 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $71.7K.
  • Amylyx Pharmaceuticals made up 0.07% of Seven Fleet Capital Management's portfolio in Q1 2026, its #101 holding.
  • Seven Fleet Capital Management first reported a position in Amylyx Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.